This list of affiliated investigators can help you identify potential research mentors at the University of Pittsburgh. PSTP students can, and do, work with mentors not on this list, but the investigators featured below have expressed interest in hosting PSTP students in their laboratories.
Robert Binder, PhD
The mechanisms of cross-priming of antigens during immune responses to cancer, viruses and autoimmunity
Lisa Borghesi , PhD
Demand adapted hematopoiesis in infection and inflammation
Craig Byersdorfer, MD, PhD
The Byersdorfer lab seeks a deeper understanding of In vivo T cell metabolism, in order to develop therapies that separate pathologic effects from physiologic and beneficial responses following allogeneic blood and marrow transplantation.
Geetha Chalasani, MD
Understanding how memory T cells are generated in transplantation
Greg Delgoffe, PhD
The metabolic regulation of T cell function, with a specific focus of those T cells that infiltrate the nutrient-poor tumor microenvironment
Louis Falo, MD, PhD
Developing a better understanding of cutaneous biology and skin immune function, and leveraging that evolving understanding to develop new skin-targeted strategies to modulate local and systemic immune responses
Robert Ferris, MD, PhD
Mechanisms of immune escape and clinical translation to therapeutic cancer immunotherapy trials
Joanne Flynn, PhD
Immunology and Pathogenesis of Tuberculosis
Timothy Hand, PhD
Understand the causes of diseases with disruptions between immune system and the microbiota, such as Crohn’s Disease and Environmental Enteropathy
Lawrence Kane, PhD
Signal Transduction; The role of the Akt kinase in NF-kB and T cell activation; Role of TIM proteins in T cell activation
Daniel Kaplan, MD, PhD
Role for nerves in the skin as modulators of immune responses
Fadi Lakkis, MD
Innate and adaptive immune response to transplanted organs and the mechanisms of transplantation tolerance
Philana Lin, MD, MSC
Our lab is focused on the host protective immune responses to M. tuberculosis, a major factor in outcome of infection.
The Lohmueller lab works on developing genetic engineering approaches to augment adoptive cell therapy (ACT) for the treatment of cancer.
Diana Metes, MD
Human immunology: Innate and adaptive immune responses to latent viruses and to allo-antigens after organ transplantation
Ana Mora, MD
The pathogenic mechanisms of Idiopathic Pulmonary Fibrosis (IPF) in aging; Mitochondrial-targeted therapies in animal models of lung fibrosis
Penelope Morel, MD
Autoimmunity & the control of T cell immune responses; Systems biology approaches to immune response to infectious organisms
Adrian Morelli, MD, PhD
The role of donor- and recipient-derived antigen-presenting cells (i.e. dendritic cells) and extracellular vesicles (i.e. exosomes, microvesicles) during allo-sensitization, graft rejection, and induction of donor-specific immunosuppression / tolerance, following transplantation
Alison Morris, MD, MS
HIV-associated lung disease; HIV-associated emphysema; Role of Pneumocystis in COPD
David Rothstein, MD
Immunoregulation: Focusing on regulatory and inflammatory B cells in transplant and autoimmune models, and their use as biomarkers in transplantation; as well as pathways by which regulatory T cells can be enhanced relative to Teffector cells
Melanie Scott, MD, PhD
Innate immune responses to sterile injury and infection with a focus on inflammasome activation and immune activation by endogenous danger signals
Mark Shlomchik, MD, PhD
My lab is interested in the establishment of long term B cell immunity and in pathogenesis of systemic autoimmune diseases and graft vs host disease.
Michael Shurin, MD, PhD
Understanding of biological and clinical significance of tumor innervation and revealing neuroimmunological pathways controlling tumor spreading and metastasis formation
Angus Thomson, PhD, DS.c.
Regulation of the immune response; role of dendritic cells and T cells in tolerance induction; mechanism of action of novel immune suppressants
Anda Vlad, MD, PhD
The Vlad lab focuses on the development of new combination therapies for ovarian cancer and identification of new mechanisms of treatment response or resistance.
Sally Wenzel, MD
Focuses on asthma phenotypes and the molecular mechanisms, particularly in the airway epithelium that control them